Lipid nanoparticles for bone marrow-targeted RNA therapeutics

⚡ 摘要
期刊 Journal Of Nanobiotechnology 类型 原创研究 (Original Research)

📄 英文摘要 English Abstract

EN

Lipid nanoparticle (LNP)-mediated delivery of therapeutic RNA molecules to the bone marrow (BM) holds transformative potential to treat hematological malignancies such as leukemia and for advancing immune and regenerative therapies. D... Parabiotics as Next-Generation Microbiome Therapeutics: Insights into Mechanisms, Evidence, and Therapeutic Potential. Current Microbiology Parabiotics (also termed paraprobiotics) are defined as non-viable microbial cells or their components, including peptidog

📄 中文摘要 Chinese Abstract

中文
脂质纳米颗粒(LNP)介导的治疗性RNA分子递送至骨髓(BM)具有变革性潜力,可用于治疗白血病等血液系统恶性肿瘤,并推动免疫和再生疗法的发展。副益生菌(也称为旁益生菌)被定义为非活性微生物细胞或其成分,包括肽聚糖。

📋 英文结构化总结 English Structured Summary

摘要整理

EN

Background:

Lipid nanoparticle (LNP)-mediated delivery of therapeutic RNA molecules to the bone marrow (BM) holds transformative potential to treat hematological malignancies such as leukemia and for advancing immune and regenerative therapies. Parabiotics (also termed paraprobiotics) are defined as non-viable microbial cells or their components, including peptidog.

Methods:

N/A - not provided in the abstract.

Results:

N/A - not provided in the abstract.

Data Summary:

N/A - no quantitative results or key statistics provided.

Conclusions:

N/A - not provided in the abstract.

Practical Significance:

The abstract points to therapeutic potential for LNP-mediated delivery of therapeutic RNA molecules to the bone marrow (BM) in hematological malignancies such as leukemia and for advancing immune and regenerative therapies, and for parabiotics as next-generation microbiome therapeutics.

📋 中文结构化总结 Chinese Structured Summary

中文

背景:

脂质纳米颗粒(LNP)介导的治疗性RNA分子递送至骨髓(BM)具有变革性潜力,可用于治疗白血病等血液系统恶性肿瘤,并推动免疫和再生疗法的发展。副益生菌(也称为旁益生菌)被定义为非活性微生物细胞或其成分,包括肽聚糖。

方法:

不适用——摘要中未提供。

结果:

不适用——摘要中未提供。

数据摘要:

不适用——未提供定量结果或关键统计数据。

结论:

不适用——摘要中未提供。

实践意义:

摘要指出,脂质纳米颗粒(LNP)介导的治疗性RNA分子递送至骨髓(BM)在白血病等血液系统恶性肿瘤中具有治疗潜力,并有助于推动免疫和再生疗法的发展;同时,副益生菌可作为下一代微生物组疗法。